reported that increased expression of Nrf-2 in gliomas, coupled with decreased expression of Keap1, significantly accelerates cell proliferation, promotes tumor formation, and impedes programmed cell death (51) (Figure 11). This evidence concerns the gene KEAP1 and glioma.